Long-Term Use and Cost-Effectiveness of Secondary Prevention Medications for Heart Disease in Western Australian Seniors

临床试验表明，用选定的药物长期治疗可大大降低已知心脏病患者进一步心脏病发作或中风的风险。当病人出院时，这种处方的水平很高，但病人继续长期治疗的程度尚不清楚。我们将在西澳大利亚州65岁或以上患者的人群研究中调查治疗依从性以及这些药物的成本和有效性。

Clinical trials show that long-term treatment with selected medicines greatly reduces the risk of further heart attacks or stroke in persons with known heart disease. Levels of such prescribing is high when patients are discharged from hospital, but the extent to which patients continue with long-term treatment is unknown. We will investigate compliance with treatment, and the costs and effectiveness of these medicines in a population study of patients aged 65 years or more in Western Australia.